WEBIntroduction. Respiratory syncytial virus (RSV) causes substantial morbid-ity and mortality in older adults, resulting in approximately 60,000–160,000 hospitalizations and 6,000–10,000 deaths annually among adults aged ≥65 years (1).
Characteristics and Outcomes Among Adults Aged ...
WEBOct 5, 2023 — Introduction. Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in older adults, resulting in approximately 60,000–160,000 hospitalizations and 6,000–10,000 deaths annually among adults aged ≥65 years (1).
Severity of Disease Among Adults Hospitalized with ...
WEBOct 28, 2021 — Delahoy MJ, Whitaker M, O’Halloran A, et al.; COVID-NET Surveillance Team. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19—COVID-NET, 13 states, March 1–August 22, 2020.
Report from the CDC: MMWR Characteristics and Outcomes …
WEBDec 1, 2023 — In May 2023, the Food and Drug Administration approved two RSV vaccines for prevention of RSV lower respiratory tract disease in adults aged ≥60 years. ∗ In June 2023, CDC recommended RSV vaccination for adults aged ≥60 years using shared clinical decision-making between patient and clinicians; † adults at highest risk for severe RSV ...
Michael Whitaker's research works | Centers for Disease Control and ...
WEBMichael Whitaker's research while affiliated with Centers for Disease Control and Prevention and other places. Overview. What is this page? This page lists the scientific contributions of...
MMWR. Morbidity and mortality weekly report, Vol. 72 ... - CDC …
WEBOct 6, 2023 — Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023 / Fiona P. Havers; Michael Whitaker; Michael Melgar; Bhoomija Chatwani et al. -- Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among ...
WEBReport from the CDC: MMWR Characteristics and Outcomes Among Adults Aged 60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023 Fiona P. Havers1,*, Michael Whitaker1, Michael Melgar1, Bhoomija Chatwani1,2, Shua J. Chai3,4, Nisha B. Alden5, James Meek6, Kyle P. Openo7,8,9,
Author Page for Michael Whitaker - SSRN
WEBGovernment of the United States of America - Centers for Disease Control and Prevention (CDC)
WEBHeidi L. Moline, MD1,2; Michael Whitaker, MPH1; Li Deng, PhD 1; Julia C. Rhodes, PhD ; Jennifer Milucky, ... person-level COVID-19 vaccination data reported to CDC by …
Developing a sampling methodology for timely reporting of …
WEBJan 10, 2023 — The first draft of the manuscript was written by Alissa O'Halloran and Michael Whitaker, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
- Some results have been removed